883749-85-7

Basic information

• Product Name: [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol
• Synonyms: [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol
• CAS NO: 883749-85-7
• Molecular Weight: 281.311
• Mol File: 883749-85-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol(883749-85-7)
• EPA Substance Registry System: [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol(883749-85-7)

Safety Data

• Hazardous Substances Data: 883749-85-7(Hazardous Substances Data)

Usage

General Description

[3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol is a chemical compound with the molecular formula C16H15NO3. It is a methanol derivative of isoxazolylphenyl compound, featuring a methanol group bound to the isoxazole ring and a benzyl ether group attached to the phenyl ring. [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol has potential applications in medicinal chemistry and pharmaceutical research due to its structural features and potential biological activities. However, further research and testing are needed to fully understand its potential uses and implications.

Upstream product

• 4397-53-9 p-benzyloxybenzaldehyde 
• 76193-67-4 4-benzyloxybenzaldehyde oxime 
• 107-19-7 propargyl alcohol 

Downstream Products

• 1105060-64-7 3-(4-benzyloxy-phenyl)-5-chloromethyl-isoxazole 
• 1295650-25-7 N-[3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl]-N,N'-di-Boc-guanidine 
• 1242296-33-8 carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester 
• 1242297-51-3 imidazole-1-carboxylic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester 
• 883749-84-6 methanesufonic acid [3-(4-benzyloxy-phenyl)isoxazol-5-ylmethyl] ester 
• 337355-81-4 3-(4-benzyloxy-phenyl)-isoxazol-5-carbaldehyde 

Relevant articles and documents

Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration

Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.

PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURON OR NEURODEGENERATION

Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.

Synthesis and biological evaluation of novel T-type Ca2+ channel blockers

A small molecule library of piperazinylalkylisoxazole derivatives containing about 600 compounds was designed, synthesized and evaluated for blocking effects on T-type Ca2+ channel. Several ligands were identified to possess high inhibitory activity against the T-type Ca 2+ channel. The compound 21 with trifluoromethyl substituents at C3-position of phenyl group (R1) and C2- position of phenyl group (R2) showed the highest inhibitory activity with IC50 value of 1.02μM, which is comparable to that of mibefradil.